EX-32.1 7 ibio-20220930xex32d1.htm EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of iBio, Inc. (the “Company”) for the quarterly period ended September 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas F. Isett 3rd , Chief Executive Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

​ ​ ​ ​ 1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and ​ ​ ​ ​ ​ ​ ​ ​ 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. ​ ​ ​ ​ ​ |  |
Date: | November 14, 2022 | /s/ Thomas F. Isett 3rd
|  | Thomas F. Isett 3rd
|  | Chief Executive Officer
|  | (Principal Executive Officer)

​